Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Prothrombin | ||
Ligand | BDBM50063555 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_208896 (CHEMBL814953) | ||
Ki | 0.1±n/a nM | ||
Citation | Lumma, WC; Witherup, KM; Tucker, TJ; Brady, SF; Sisko, JT; Naylor-Olsen, AM; Lewis, SD; Lucas, BJ; Vacca, JP Design of novel, potent, noncovalent inhibitors of thrombin with nonbasic P-1 substructures: rapid structure-activity studies by solid-phase synthesis. J Med Chem41:1011-3 (1998) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Prothrombin | |||
Name: | Prothrombin | ||
Synonyms: | Activation peptide fragment 1 | Activation peptide fragment 2 | Coagulation factor II | F2 | Prothrombin precursor | THRB_HUMAN | Thrombin heavy chain | Thrombin light chain | ||
Type: | Protein | ||
Mol. Mass.: | 70029.57 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P00734 | ||
Residue: | 622 | ||
Sequence: |
| ||
BDBM50063555 | |||
n/a | |||
Name | BDBM50063555 | ||
Synonyms: | 1-(2-Amino-3,3-diphenyl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide | CHEMBL269744 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H36N4O2 | ||
Mol. Mass. | 448.6003 | ||
SMILES | NC(C(c1ccccc1)c1ccccc1)C(=O)N1CCCC1C(=O)NC[C@H]1CC[C@H](N)CC1 |wU:26.28,wD:29.32,(6.26,-10.67,;4.93,-9.9,;3.6,-10.69,;3.6,-12.23,;2.27,-13,;2.27,-14.52,;3.6,-15.29,;4.95,-14.51,;4.93,-12.98,;2.27,-9.92,;2.27,-8.36,;.92,-7.59,;-.41,-8.36,;-.41,-9.92,;.92,-10.69,;4.93,-8.36,;3.6,-7.59,;6.26,-7.59,;5.79,-6.14,;7.03,-5.23,;8.27,-6.14,;7.8,-7.59,;8.69,-8.85,;8.69,-10.39,;10.02,-8.06,;11.36,-8.83,;12.68,-8.05,;12.65,-6.51,;14,-5.72,;15.34,-6.47,;16.67,-5.7,;15.36,-8.01,;14.05,-8.8,)| | ||
Structure |